Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 for prevention of recurrent wheezing exacerbations in high-risk preschool children
ACTRN12619000864123Phase 3Not yet recruiting
- Sponsor
- The University of Western Australia
- Start
- Jul 2019
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoints: Total number of respiratory exacerbations and Time to next respiratory exacerbation. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
OM-85
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12619000864123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000864123.